Partnering challenge
Ensure your preclinical success dictates human clinical reality
Product

Ensure your preclinical success dictates human clinical reality
Engine
PhenoLink™ is an expert-curated translational platform that bridges the gap between preclinical discovery and clinical success. By optimizing animal model selection and intelligently scoring their translational feasibility against actual human clinical features, the platform fundamentally transforms preclinical data from observational to predictive.
Workflow
The TechMulti-source database engines data-mined across >15 quality-assured data repositories.
Value AddedPinpoints the exact animal models that align structurally with your target human disease biology.
The TechProprietary machine learning models linked directly to fine-tuned PubMed repositories.
Value AddedExplicitly assesses how well a chosen model presents human clinical features, ensuring high-fidelity phenotypic reliability.
The TechOpposing phenotype identification and biological divergence algorithms.
Value AddedDe-risks development by automatically flagging conflicting or opposite phenotypes between rodents and humans.
The TechGranular tiered scoring matrices and disease-specific biomarker relevance trackers.
Value AddedDelivers a predictive, multi-factorial benchmarking score that shifts data extraction and estimation timelines from weeks to hours.
Evidence
Multiple use cases with HuntX pharma and other academic partners
Compresses traditional 21-30 day model scoring and recommendation timelines down into a 4-5 day window.
Powered by direct access to top-tier laboratories from Université Paris Cité and the Karolinska Institutet.
Formally deployed and relied upon by translational leaders, including IPSEN pharmaceuticals and the Institut Necker Enfants Malades (INEM).
For partners
Ensure your preclinical success dictates human clinical reality
Eliminate the translational blind spot by matching the exact animal model to your target human disease phenotype.
Tiered animal model phenotypic scores, trial-relevant biomarker relevance briefs, and translational feasibility reports.
100% EU-hosted; built by researchers and machine learning engineers to be completely verifiable, traceable, explainable, and auditable.
Flexible annual platform subscription (following fee-for-build) or project-specific Contract Research Agreement (CRA).
Partner with MedInsights